Profile photo Pieter Doevendans

Pieter Doevendans

Full Professor

Biography

Pieter A. Doevendans became a cardiologist in Maastricht (trained by H. Wellens) after his medical training at the Leiden University. In 1993-1994 he had the opportunity to work with Ken Chien at the University of California San Diego, where the work on embryonic stem cells started. The work was completed in Maastricht and provided the basis for a thesis on the function of the promoter of the atrial Myosin Light Chain gene. Upon return in The Netherlands he worked with Christine Mummery and Hans Clevers on both human Embryonic as well as human Cardiac stem cells. In the meantime he remained active as an interventional cardiologist initially in Maastricht, but from 2002 on in Utrecht at the UMC Utrecht. Here he was appointed full professor in Translational Cardiology in 2004 and head of the department in 2005. The focus of the department of cardiology is on Cardiac Failure, Stem Cells and Genetics. He was funded by various national and international foundations. Thus far (2017) he published more than 700 peer reviewed papers and 11 books

Research groups

Inherited heart disease (cardiogenetics)

Research aim

We aim to enhance patient and family lives impacted by inherited cardiomyopathies. Our efforts target gene and variant identification, disease mechanisms, factors influencing disease outcomes, therapy optimization, and exploration of novel therapies.

Go to group

Recent publications

A Cardioprotective perfusion protocol limits myocardial functional decline during ex situ heart perfusion Mats T. Vervoorn, Elisa M. Ballan, Sjoerd van Tuijl, Saskia C.A. de Jager, Selma E. Kaffka genaamd Dengler, Joost P.G. Sluijter, Pieter A. Doevendans, Niels P. van der Kaaij
JHLT Open, 2024, vol. 3
Predictors of major adverse cardiac events among patients with chest pain and low HEART score in the emergency department Andrew Fu Wah Ho, Chun En Yau, Jamie Sin Ying Ho, Swee Han Lim, Irwani Ibrahim, Win Sen Kuan, Shirley Beng Suat Ooi, Mark Y. Chan, Ching Hui Sia, Arend Mosterd, Crystel M. Gijsberts, Vince C. de Hoog, Ingrid E.M. Bank, Pieter A. Doevendans, Dominique P.V. de Kleijn
International Journal of Cardiology, 2024, vol. 395
ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathy Rutger R. van de Leur, Remco de Brouwer, Hidde Bleijendaal, Tom E. Verstraelen, Belend Mahmoud, Ana Perez-Matos, Cathelijne Dickhoff, Bas A. Schoonderwoerd, Tjeerd Germans, Arjan Houweling, Paul A. van der Zwaag, Moniek G.P.J. Cox, J. Peter van Tintelen, Anneline S.J.M. te Riele, Maarten P. van den Berg, Arthur A.M. Wilde, Pieter A. Doevendans, Rudolf A. de Boer, René van Es
Heart Rhythm, 2024, vol. 21, p.1102-1112
Hypothermic and cryogenic preservation of cardiac tissue-engineered constructs Jasmijn Janssen, Nino Chirico, Madison J Ainsworth, Gerardo Cedillo-Servin, Martina Viola, Inge Dokter, Tina Vermonden, Pieter A Doevendans, Margarida Serra, Ilja K Voets, Jos Malda, Miguel Castilho, Linda W van Laake, Joost P G Sluijter, Vasco Sampaio-Pinto, Alain van Mil
Biomaterials science, 2024, vol. 12, p.3866-3881
In-hospital mortality of patients with acute coronary syndrome (ACS) after implementation of national health insurance (NHI) in Indonesia Nurul Qalby, Dian S. Arsyad, Andriany Qanitha, Maarten J. Cramer, Yolande Appelman, Dara R. Pabittei, Pieter A. Doevendans, Idar Mappangara, Akhtar Fajar Muzakkir
BMC Health Services Research, 2024, vol. 24
Automatic triage of twelve-lead electrocardiograms using deep convolutional neural networks Rutger R. van de Leur, Meike T.G.M. van Sleuwen, Peter Paul M. Zwetsloot, Pim van der Harst, Pieter A. Doevendans, Rutger J. Hassink, René van Es
European Heart Journal - Digital Health, 2024, vol. 5, p.89-96

Fellowships & Awards

2000: Fellow of the European Society of Cardiology

External positions

Scientific advisor, HeartEye

Honorary Ambassador PLN Foundation

Scientific advisor , AMT

Member of the directory board, Netherlands Heart Institute

CAT , European Medicines Agency (EMA)